Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients

Manabu Yamamoto, Hideo Baba, Yasushi Toh, Takeshi Okamura, Yoshihiko Maehara

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: We recently found an elevation in the pre-operative peritoneal lavage carcinoembryonic antigen (CEA) level to be associated with an earlier detection of recurrent peritoneal dissemination and a poor prognosis. Method: Two hundred and twenty-nine patients with gastric cancer were intraoperatively measured for tumor markers, CEA and CA125 based on peritoneal lavage using a chemiluminescent enzyme immunoassay. Results: The patients were divided into four groups. (A) The peritoneal lavage CEA (-) CA125 (-) group (CEA < 0.4 ng/ml, CA125 < 200 ng/ml, n = 129); (B) the peritoneal lavage CEA (-) CA125 (+) group (CEA < 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 50); (C) the peritoneal lavage CEA (+) CA125 (-) group (CEA ≧ 0.4 ng/ml, CA125 < 200 ng/ml, n = 18); and (D) the peritoneal lavage CEA (+) CA125 (+) group (CEA ≧ 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 32). The 5-year survival of the patients in groups C and D was 40 and 26%, respectively, which was lower than that of the patients in any other group (group A, B; p < 0.0001). Recurrent sites were both peritoneal dissemination and lymph node/liver in group C, while those were only peritoneal dissemination in group D. Conclusion: This combined analysis of these markers is therefore considered to be helpful method to accurately estimate the recurrent sites and prognosis for advanced gastric cancer patients.

Original languageEnglish
Pages (from-to)471-476
Number of pages6
JournalJournal of Cancer Research and Clinical Oncology
Volume133
Issue number7
DOIs
Publication statusPublished - Jul 1 2007

Fingerprint

CA-125 Antigen
Peritoneal Lavage
Carcinoembryonic Antigen
Stomach Neoplasms
Differentiation Antigens
Tumor Biomarkers
Immunoenzyme Techniques

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. / Yamamoto, Manabu; Baba, Hideo; Toh, Yasushi; Okamura, Takeshi; Maehara, Yoshihiko.

In: Journal of Cancer Research and Clinical Oncology, Vol. 133, No. 7, 01.07.2007, p. 471-476.

Research output: Contribution to journalArticle

Yamamoto, Manabu ; Baba, Hideo ; Toh, Yasushi ; Okamura, Takeshi ; Maehara, Yoshihiko. / Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. In: Journal of Cancer Research and Clinical Oncology. 2007 ; Vol. 133, No. 7. pp. 471-476.
@article{3f72847fe9054ecaa91667d06ad396f6,
title = "Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients",
abstract = "Background: We recently found an elevation in the pre-operative peritoneal lavage carcinoembryonic antigen (CEA) level to be associated with an earlier detection of recurrent peritoneal dissemination and a poor prognosis. Method: Two hundred and twenty-nine patients with gastric cancer were intraoperatively measured for tumor markers, CEA and CA125 based on peritoneal lavage using a chemiluminescent enzyme immunoassay. Results: The patients were divided into four groups. (A) The peritoneal lavage CEA (-) CA125 (-) group (CEA < 0.4 ng/ml, CA125 < 200 ng/ml, n = 129); (B) the peritoneal lavage CEA (-) CA125 (+) group (CEA < 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 50); (C) the peritoneal lavage CEA (+) CA125 (-) group (CEA ≧ 0.4 ng/ml, CA125 < 200 ng/ml, n = 18); and (D) the peritoneal lavage CEA (+) CA125 (+) group (CEA ≧ 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 32). The 5-year survival of the patients in groups C and D was 40 and 26{\%}, respectively, which was lower than that of the patients in any other group (group A, B; p < 0.0001). Recurrent sites were both peritoneal dissemination and lymph node/liver in group C, while those were only peritoneal dissemination in group D. Conclusion: This combined analysis of these markers is therefore considered to be helpful method to accurately estimate the recurrent sites and prognosis for advanced gastric cancer patients.",
author = "Manabu Yamamoto and Hideo Baba and Yasushi Toh and Takeshi Okamura and Yoshihiko Maehara",
year = "2007",
month = "7",
day = "1",
doi = "10.1007/s00432-006-0189-2",
language = "English",
volume = "133",
pages = "471--476",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients

AU - Yamamoto, Manabu

AU - Baba, Hideo

AU - Toh, Yasushi

AU - Okamura, Takeshi

AU - Maehara, Yoshihiko

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Background: We recently found an elevation in the pre-operative peritoneal lavage carcinoembryonic antigen (CEA) level to be associated with an earlier detection of recurrent peritoneal dissemination and a poor prognosis. Method: Two hundred and twenty-nine patients with gastric cancer were intraoperatively measured for tumor markers, CEA and CA125 based on peritoneal lavage using a chemiluminescent enzyme immunoassay. Results: The patients were divided into four groups. (A) The peritoneal lavage CEA (-) CA125 (-) group (CEA < 0.4 ng/ml, CA125 < 200 ng/ml, n = 129); (B) the peritoneal lavage CEA (-) CA125 (+) group (CEA < 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 50); (C) the peritoneal lavage CEA (+) CA125 (-) group (CEA ≧ 0.4 ng/ml, CA125 < 200 ng/ml, n = 18); and (D) the peritoneal lavage CEA (+) CA125 (+) group (CEA ≧ 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 32). The 5-year survival of the patients in groups C and D was 40 and 26%, respectively, which was lower than that of the patients in any other group (group A, B; p < 0.0001). Recurrent sites were both peritoneal dissemination and lymph node/liver in group C, while those were only peritoneal dissemination in group D. Conclusion: This combined analysis of these markers is therefore considered to be helpful method to accurately estimate the recurrent sites and prognosis for advanced gastric cancer patients.

AB - Background: We recently found an elevation in the pre-operative peritoneal lavage carcinoembryonic antigen (CEA) level to be associated with an earlier detection of recurrent peritoneal dissemination and a poor prognosis. Method: Two hundred and twenty-nine patients with gastric cancer were intraoperatively measured for tumor markers, CEA and CA125 based on peritoneal lavage using a chemiluminescent enzyme immunoassay. Results: The patients were divided into four groups. (A) The peritoneal lavage CEA (-) CA125 (-) group (CEA < 0.4 ng/ml, CA125 < 200 ng/ml, n = 129); (B) the peritoneal lavage CEA (-) CA125 (+) group (CEA < 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 50); (C) the peritoneal lavage CEA (+) CA125 (-) group (CEA ≧ 0.4 ng/ml, CA125 < 200 ng/ml, n = 18); and (D) the peritoneal lavage CEA (+) CA125 (+) group (CEA ≧ 0.4 ng/ml, CA125 ≧ 200 ng/ml, n = 32). The 5-year survival of the patients in groups C and D was 40 and 26%, respectively, which was lower than that of the patients in any other group (group A, B; p < 0.0001). Recurrent sites were both peritoneal dissemination and lymph node/liver in group C, while those were only peritoneal dissemination in group D. Conclusion: This combined analysis of these markers is therefore considered to be helpful method to accurately estimate the recurrent sites and prognosis for advanced gastric cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=34249063058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249063058&partnerID=8YFLogxK

U2 - 10.1007/s00432-006-0189-2

DO - 10.1007/s00432-006-0189-2

M3 - Article

VL - 133

SP - 471

EP - 476

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 7

ER -